Pause

blankRegister With NARSAContact USSeachable Isolate Inventory Database, On-line Strain Request Form  Login RequiredStaph LinksRead details about our programFrequently asked questions Home PageNARSA forumblank

PRESENTATIONS AND PUBLICATIONS

Publications/ Posters

  1. Genetic changes associated with glycopeptide resistane in S.aureus: Predominance of aminoacid substitutions in YvqF/VraSR by Maebashi Kazunori et al.
  2. Recovery & Indentification of CA MRSA using BBL CHROMagar MRSA II and BBL CHROMagar MRSA by V. Ritter et al.
  3. Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin, trimethoprim/sulfamethoxizole against community associated MRSA by George P. Allen and Lalithagauri M. Deshpande
  4. Infection Control by Antibody Discription of Bacterial Quorum Sensing Signaling by Junguk Park et al.
  5. In vitro Activity of Oritavancin against ca-MRSA, VISA & DNSSA by Louis Saravolatz et al.
  6. In vitro Activity of Ceftaroline against ca-MRSA, VISA, VRSA, and Daptomycin-nonsusceptible Staph. aureus by Louis D. Saravolatz et al.
  7. Two-Year Study Evaluating the Potential Loss of Methicillin Resistance in a Methicillin-Resistant Staph. aureus Culture Collection by William Veguilla, et al
  8. Detection of Vancomycin - Intermediate S. aurues With the Updated Trek- Sensititre System and the MicroScan System by Rohan Nadarajah et al.
  9. Comparative genomics and DNA array-based genotyping of pandemic Staph aureus strains encoding Panton-Valentine leukocidin by S. Monecke, B. Berger-Bachi, G. Coombs, et al.
  10. Assignment of Staph. aureus isolates to clonal complexes based on microarray analysis and pattern recognition by Stefan Monecke, Peter Slicker, & Ralf Ehricht

The 9th NARSA Annual Investigators Meeting Presentations

  1. Agents of Change: Enterococcal mobile genetic elements and their relations with Staphylococcus aureus by KEITH E. WEAVER, PH.D., UNIVERSITY OF SOUTH DAKOTA, SANFORD SCHOOL OF MEDICINE
  2. Role of S. aureus PPB2 in cell wall synthesis and autolysis by Alexander Tomasz & Aude Antignac, The Rockefeller University, NY
  3. VRSA Update from CDC by Jean B. Patel, PhD, (D)ABMM, Leader, Antimicrobial Resistance Team
  4. Restriction-Modification and its Potential Impact on vanA Transfer by Jodi A. Lindsay
  5. Coagulase-Negative Staphylococci: Genetic Reservoirs for Antimicrobial Resistance- Key Note by Gordon L. Archer MD, Virginia Commonwealth University, School of Medicine
  6. Vaccine Protection Against Staphylococcus aureus Pneumonia by Juliane Bubeck Wardenburg, MD, Univ. of Chicago, Depts of Pediatrics & Microbio
  7. Genetic basis of susceptibility to S. aureus by Hitesh Deshmukh MD, PhD,
  8. The NIAID-Sponsored Pathogen Functional Genomics Resource Center: Reaching Out to Scientific Communities by Scott Peterson, PhD, JCVI (the institute formerly known as TIGR)
  9. Network for Antibacterial Resistance in Staphylococcus aureus by N. Kent Peters, Ph.D. , NIAID, NIH
  10. Sensing and Responding to Mechanism of Innate Host Defense in Staphylococci by Michael Otto, PhD, Rocky Mount. Lab, Lab of Human Bacterl Pathogen, NIAID/NIH
  11. Genotyping The NARSA Collection by Barry N. Kreiswirth, PhD, PHRI
  12. Identification of Ligand Specificity Determinants in AgrC by Eddie Geisinger, MD-PhD student
  13. NARSA Activities (Past & Future) by Dan F. Sahm, Ph.D., President, Eurofins Medinet, Inc

The 10th NARSA Annual Investigators Meeting Presentations

  1. agr Function in Clinical S. aureus Infections by Bo Shopsin, MD-PhD
  2. The Pros of Decolonizing as a Strategy for Hospital Infections by Jan Kluytmans, MD, PhD
  3. MRSA (Messenger RNA Stabilizing Agents) vs. MRSA by Patrick Olson
  4. Genes Identified by in silico Haplotype Mapping as Associated w Susceptibility to Staph aureus Infection have mRNA Expression Profiles that Differ bw Susceptible & Resistance Mouse by Strains by Nicole Johnson
  5. The Emergence and Spread of S. aureus Strain ST398 by Frank Lowy, PhD, Prof of Med & Pathology, Columbia U, New York, NY
  6. NARSA Updates by Dan Sahm, PhD, President, Eurofins Medinet, Chantilly, VA
  7. Candida albicans and Staphylococcus aureus Mixed-Species Biofilms by Brian Peters, University of MD. Baltimore
  8. Rapid MRSA Diagnostics/the Mol Biol of the Targets/Roles in Surveillance by Richard V. Goering, Ph.D.
  9. The Role of Staphyloxanthin in S. aureus Pathogenesis by George Liu, MD, PhD
  10. Drugs in the Pipeline by Helen W. Boucher, MD, FACP
  11. MRSA Updates from CDC by Roberta B. Carey, Ph.D.

The 11th NARSA Annual Investigators Meeting Presentations

  1. NIAID Genomic Resources for Scientific Community by Dr. Maria Y. Giovanni
  2. What Have We and Will We Learn from Staphylococcal Genomics, the Challenges Ahead by Barry Kreiswirth
  3. Hybrid Clones of S.aureus, Evolution and Epidemiology by Dr.Ashley Robinson
  4. The Nebraska Mutant Library by Dr. Ken Bayles & Dr. Paul Fey
  5. RNA Stability, New Drug Target by Dr. Paul M. Dunman
  6. Active Surveillance and Decolonization for MRSA Control: Can We Do Little or Too Much? by Dr. Lance R. Peterson
  7. Updates from CDC by Dr. Roberta B. Carey
  8. Active Surveillance and Decolonization for MRSA Control: Can We Do Little or Too Much? by Daniel J. Diekema
  9. Host Gene Expression Signatures of S.aureus by SunHee Ahn
  10. Turning Virulence of Determinants in S.aureus with Small Molecules by Fei Sun
  11. Updates from NIH by Dr. Clayton Huntley
  12. IDSA Clinical Practice Guidelines for the Treatment of MRSA Infections by Catherine Liu

The 12th NARSA Annual Investigators Meeting Presentations

  1. Staphylococcal agr Locus: Temporal Expression Coordinated Through Regulation by Virulence Factors AgrA, SarA & SarR by Dindo Y. Reyes
  2. 52-Sequenced Strains by Gordon Archer
  3. Staphylococcal Genomes: Phylogeny, Virulence, & Drug Resistance by Scott Peterson
  4. Resolution of MRSA biofilm infection by vaccination and antimicrobial therapy by Graeme A. O'May
  5. Non-toxigenic protein A vaccine for MRSA infections in mice by Hwan Keun Kim
  6. The Nebraska Transposon Mutant Library by Ken Bayles & Paul Fey
  7. ESKAPE ORGANISMS:Update on Antibiotic Resistance by Henry F. Chambers
  8. Update from NIAID by Clayton Huntley
  9. sigB and other sigma factors in mediating stress response of S.aureus by Ambrose Cheung
  10. Linezolid v. Vancomycin for the Treatment of Necrotizing Pneumonia Caused by Community-associated MRSA by Hoan Le
  11. Update on CDC S.aureus activities by Brandi Limbago
  12. The Battle for Metal Between S.aureus and its Host by Eric Skaar

The 13th NARSA Annual Investigators Meeting Presentations

  1. Laboratory Detection of Methicillin - Resistant Staphylococci; Evolving Practices and Future Challenges by Dr. Ellen Jo Baron
  2. Anti-MRSA Beta-Lactams: A Clinical Perspective by Dr. Henry Chambers
  3. Comparative Genomics of the Staphylococci by Dr. Paul Planet
  4. Tannic Acid Inhibits S. aureus Biofilm Formation in an ISaA Dependent Manner by David Payne
  5. The use of Bioflux Technology to Visualize Differential Gene Expression During Biofilm Development by Dr. Kenneth Bayles
  6. A Scientist's Perspective on the Promises and Potential of Anti - MRSA Beta-Lactam Antibiotics by Dr. Karen Bush
  7. NIAID Update by Dr. Clayton Huntley
  8. Prophylactic and Therapeutic Efficacy of an Anti-Alpha Toxin mAb by Dr. Bret Sellman
  9. Neutrophil-Derived IL-1Beta is Required for Abscess Formation in Immunity Against S. aureus by John Cho

The 14th NARSA Annual Investigators Meeting Presentations

  1. Nature of VRSA from their Genomes by Dr. Michael Gilmore
  2. Aureolysin-mediated remodeling of the Sae exoproteome impacts the pathogenesis of Staphylococcus aureus osteomyelitis by Dr. Jim Cassat
  3. NARSA Genomic Library by Dr. Daniel Sahm
  4. Genomic expansion imposes a fitness cost on antibiotic resistant Enterococcus faecalis by Dr. Matthew M. Ramsey
  5. Sub-MIC concentrations of β-lactam antibiotics induce MRSA biofilm formation by Brian O. Piotrowski
  6. Why is erythromycin resistance inducible? by Pulkit Gupta
  7. New Anti‐Staphylococcal Agents by Dr. George M. Eliopoulos
  8. MRSA Induces Inflammatory Macrophage Death by Kipyegon Kitur
  9. The 14th NARSA Annual Investigator Meeting Update from NIAID by Dr. Clayton Huntley
  10. Toward rapid S. aureus genome analysis by Dr. Timothy Read
  11. Triclosan Induces Surface Colonization of Staphylococcus aureus by Adnan Syed
  12. The Nebraska Transposon Mutant Library by Dr. Kenneth Bayles